acebutolol has been researched along with ferrous fumarate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Amrein, K; Drexler, C; Lindenau, I; Macher, S; Sareban, N; Schlenke, P | 1 |
Aarts, EO; Berends, FJ; Boerboom, A; de Boer, H; de Bruyn Kops, M; de Raaff, C; Janssen, IMC; Schijns, W; van Laarhoven, CJHM; van Wagensveld, B | 1 |
Aliu, A; Bertrams Maartens, IA; Bevers, N; Escher, H; Oudshoorn, A; Pierik, MJ; Raijmakers, M; Rezazadeh Ardabili, A; Rosias, P; Stapelbroek, J; Teklenburg, S; van de Feen, C; Van de Vijver, E; van Rheenen, PF; Vande Velde, S; Vreugdenhil, A; Winkens, B | 1 |
2 trial(s) available for acebutolol and ferrous fumarate
Article | Year |
---|---|
A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery.
Topics: Administration, Intravenous; Administration, Oral; Adult; Dietary Supplements; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Gastric Bypass; Humans; Iron Compounds; Iron Deficiencies; Maltose; Postoperative Complications; Treatment Outcome | 2020 |
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Child; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Iron; Maltose; Treatment Outcome | 2023 |
1 other study(ies) available for acebutolol and ferrous fumarate
Article | Year |
---|---|
High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biomarkers; Blood Donors; Clinical Protocols; Deficiency Diseases; Erythrocyte Count; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Male; Maltose; Middle Aged; Prospective Studies; Research Design; Time Factors; Transferrin; Treatment Outcome; Young Adult | 2016 |